{
  "id": "601dc46c1cb411341a000050",
  "type": "yesno",
  "question": "Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?",
  "ideal_answer": "Is MIS-C or Multisystem Inflammatory Syndrome in children a complication of Covid-19? Yes, it is.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33278107",
    "http://www.ncbi.nlm.nih.gov/pubmed/33243303",
    "http://www.ncbi.nlm.nih.gov/pubmed/32925547",
    "http://www.ncbi.nlm.nih.gov/pubmed/32463092",
    "http://www.ncbi.nlm.nih.gov/pubmed/33042918",
    "http://www.ncbi.nlm.nih.gov/pubmed/32631771",
    "http://www.ncbi.nlm.nih.gov/pubmed/33180935",
    "http://www.ncbi.nlm.nih.gov/pubmed/32953455",
    "http://www.ncbi.nlm.nih.gov/pubmed/32532619",
    "http://www.ncbi.nlm.nih.gov/pubmed/32755212",
    "http://www.ncbi.nlm.nih.gov/pubmed/33083367",
    "http://www.ncbi.nlm.nih.gov/pubmed/32935083",
    "http://www.ncbi.nlm.nih.gov/pubmed/33055501",
    "http://www.ncbi.nlm.nih.gov/pubmed/32946801",
    "http://www.ncbi.nlm.nih.gov/pubmed/32827525",
    "http://www.ncbi.nlm.nih.gov/pubmed/33042116",
    "http://www.ncbi.nlm.nih.gov/pubmed/33011038",
    "http://www.ncbi.nlm.nih.gov/pubmed/32496723",
    "http://www.ncbi.nlm.nih.gov/pubmed/33180050",
    "http://www.ncbi.nlm.nih.gov/pubmed/33110725",
    "http://www.ncbi.nlm.nih.gov/pubmed/33263635",
    "http://www.ncbi.nlm.nih.gov/pubmed/33300011",
    "http://www.ncbi.nlm.nih.gov/pubmed/32923992",
    "http://www.ncbi.nlm.nih.gov/pubmed/32837148",
    "http://www.ncbi.nlm.nih.gov/pubmed/33295957",
    "http://www.ncbi.nlm.nih.gov/pubmed/32839782",
    "http://www.ncbi.nlm.nih.gov/pubmed/32493734",
    "http://www.ncbi.nlm.nih.gov/pubmed/33269352",
    "http://www.ncbi.nlm.nih.gov/pubmed/33263756",
    "http://www.ncbi.nlm.nih.gov/pubmed/32975439",
    "http://www.ncbi.nlm.nih.gov/pubmed/32995826",
    "http://www.ncbi.nlm.nih.gov/pubmed/32966765",
    "http://www.ncbi.nlm.nih.gov/pubmed/33217259",
    "http://www.ncbi.nlm.nih.gov/pubmed/32511374"
  ],
  "snippets": [
    {
      "text": "Much remains unknown about the risk factors, pathogenesis, prognosis, and specific therapy for this emerging manifestation of COVID-19 known as Multisystem Inflammatory Syndrome in Children (MIS-C).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32493734",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463092",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33055501",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33055501",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A complication is the rare multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, presenting 4-6\u00a0weeks after infection as high fever, organ dysfunction, and strongly elevated markers of inflammation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32966765",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We apply systems-level analyses of blood immune cells, cytokines, and autoantibodies in healthy children, children with Kawasaki disease enrolled prior to COVID-19, children infected with SARS-CoV-2, and children presenting with MIS-C. We find that the inflammatory response in MIS-C differs from the cytokine storm of severe acute COVID-19, shares several features with Kawasaki disease, but also differs from this condition with respect to T\u00a0cell subsets, interleukin (IL)-17A, and biomarkers associated with arterial damage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32966765",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19) is a rare and challenging diagnosis requiring early treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32946801",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This syndrome is now known as either \"Pediatric Inflammatory Multisystem Syndrome temporally related with COVID-19\" (PIMS-TS) (1), or Multisystem Inflammatory Syndrome in Children (MIS-C) (2) and is currently considered a rare post-COVID-19 complication which, in a minority of cases, can lead to death.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33042918",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multisystem Inflammatory Syndrome in Children (MIS-C) associated with Coronavirus Disease 2019 (COVID-19) is a newly recognized condition in which children with recent SARS-CoV-2 infection present with a constellation of symptoms including hypotension, multiorgan involvement, and elevated inflammatory markers. Thes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32511374",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Kawasaki-like syndrome occurring in children during the COVID-19 pandemic has been labelled multisystem inflammatory syndrome in children (MIS-C) by the CDC and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) by ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33083367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "em inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection. This revie",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33263635",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: A small subset of pediatric patients develop a rare syndrome associated with Coronavirus Disease 2019 (COVID-19) infection called multisystem inflammatory syndrome in childr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33011038",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " adults. However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been associated with cardiac complicat",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32975439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection i",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33243303",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease (COVID-19) is a rare and challenging diagnosis requiring early tr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32946801",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Multisystem inflammatory syndrome in children (MIS-C), also known as pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that is temporally associated with coronavirus disease 2019 (",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32923992",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent COVID-19 publications describe a variety of clinical presentations including an asymptomatic state, pneumonia, a hemophagocytic lymphohistiocytosis like syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C) but, also called Pediatric Inflammatory Multisystem Syndrome-Toxic Shock (PIMS-TS), Kawasaki Disease, and myocarditis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33042116",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We analyzed peripheral blood immune responses in hospitalized SARS-CoV-2 infected pediatric patients (pediatric COVID-19) and patients with MIS-C. MIS-C patients had patterns of T cell-biased lymphopenia and T cell activation similar to severely ill adults, and all patients with MIS-C had SARS-CoV-2 spike-specific antibodies at admission.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32995826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33263635",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It includes a discussion of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, as well as other aspects of the COVID-19 pandemic that are affecting children and families, such as poisonings, childhood immunizations, mental health, nonaccidental trauma, and neglect.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32496723",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Importance: To date, no study has characterized the mucocutaneous features seen in hospitalized children with multisystem inflammatory syndrome in children (MIS-C) or the temporal association of these findings with the onset of systemic symptoms.Objective: To describe the mucocutaneous findings seen in children with MIS-C during the height of the coronavirus disease 2019 (COVID-19) pandemic in New York City in 2020.Design, Setting, and Participants: A retrospective case series was conducted of 35 children admitted to 2 hospitals in New York City between April 1 and July 14, 2020, who met Centers for Disease Control and Prevention and/or epidemiologic criteria for MIS-C.Main Outcomes and Measures: Laboratory and clinical characteristics, with emphasis on mucocutaneous findings, of children who met criteria for MIS-C.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33295957",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This condition, since defined as the multisystem inflammatory syndrome in children (MIS-C), is assumed to be a delayed immune response to coronavirus disease 2019 (COVID-19), and there are frequently cardiac manifestations of ventricular dysfunction and/or coronary artery dilation.Methods: We surveyed the inpatient MIS-C management approaches of the members of the International Kawasaki Disease Registry across 38 institutions and 11 countries.Results: Among the respondents, 56% reported using immunomodulatory treatment for all MIS-C patients, regardless of presentation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32935083",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "DESIGN: Children ages 0-22\u00a0years with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection presenting to urgent care clinics or being hospitalized for confirmed/suspected SARS-CoV-2 infection or multisystem inflammatory syndrome in children (MIS-C) at Massachusetts General Hospital were offered enrollment in the Massachusetts General Hospital Pediatric COVID-19 Biorepository.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32827525",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We recently discovered a superantigen-like motif, similar to Staphylococcal enterotoxin B (SEB), near the S1/S2 cleavage site of SARS-CoV-2 Spike protein, which might explain the multisystem-inflammatory syndrome (MIS-C) observed in children and cytokine storm in severe COVID-19 patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33269352",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: An extensive search strategy was conducted by combining the terms multisystem inflammatory syndrome in children and coronavirus infection or using the term multisystem inflammatory syndrome in children in bibliographic electronic databases (PubMed, EMBASE, and CINAHL) and in preprint servers (BioRxiv.org and MedRxiv.org) following the Preferred Reporting Items for Systematic Reviews and Metaanalyses guidelines to retrieve all articles published from January 1, 2020, to July 31, 2020.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32925547",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33263756",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32839782",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33300011",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Data on multisystem inflammatory syndrome in children (MIS-C) related to coronavirus disease-19 (COVID-19) is increasing in the current COVID-19 pandemic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32953455",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Introduction Multisystem inflammatory syndrome in children (MIS-C) is a unique clinical complication of SARS-CoV-2 infection observed in pediatric patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33180050",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33180050",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Case presentation An eight-year-old female presented with hyperglycemia, ketosis and metabolic acidosis consistent with diabetic ketoacidosis (DKA) in the setting of fever, rash, respiratory distress, hemodynamic instability, reduced systolic function with dilation of the left anterior descending artery, and positive SARS-CoV-2 antibodies suggestive of MIS-C.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33180050",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, the newly described multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been associated with cardiac complications.M",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32975439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32532619",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Many of these cases feature a toxic shock-like syndrome or Kawasaki-like syndrome in the setting of SARS-CoV-2 positive diagnostic testing and the CDC has termed this presentation Multisystem Inflammatory Syndrome (MIS-C).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32532619",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We describe a case of MIS-C in a child who presented to our Emergency Department (ED) twice and on the second visit was found to have signs of distributive shock, multi-organ injury and systemic inflammation associated with COVID-19.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32532619",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE OF REVIEW: Here we summarize current knowledge about multisystem inflammatory syndrome in children (MIS-C), a presumed postinfectious inflammatory condition that has emerged as an important COVID-19-associated complication, to help clinicians identify and manage cases.RECENT FINDINGS: Clinical presentation of MIS-C is do",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33278107",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MIS-C is a rare yet severe and highly critical complication of COVID-19 infection in pediatrics, leading to serious and life-threatening illnesses.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33110725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: A multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) has recently been described.OBJECTIVE: To evaluate imaging findings of MIS-C associated with COVID-19.SUBJECTS AND METHODS: Imaging studies and medical records of sixteen patients (0-20 years) admit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32755212",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Recently, cases of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 have been reporte",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33180935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent reports have described a secondary Multisystem Inflammatory Syndrome in Children (MIS-C) after a prior COVID-19 infection that often has features of Kawasaki disease (KD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32631771",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " discharged home (length of hospital stay 3-20 days). There were no mortalities.CONCLUSION: MIS-C associated with COVID-19 is characterized predominantly by cardiovascular abnormalities, though also solid visceral organ, gallbladder, and bowel abnormalities as well as ascites, reflecting a multisystemic inflammatory process.CLINICAL IMPACT: The constellation of imaging findings in the setting of COVID-19 may alert pediatr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32755212",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33110725",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33243303",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ric patients. An association between COVID-19 and a Kawasaki-like inflammatory syndrome has recently presented in pediatric patients.CASE REPORT: We report a unique case of multisystem inflammatory syndrome in children presenting with characteristic findings in a child who later developed cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.CONCLUSION: Recognition of these early signs and symptoms facilitates screening and risk stratification of pediatric COVID-19 cas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33217259",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32837148",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}